Cargando…

Effects of urolithin A on osteoclast differentiation induced by receptor activator of nuclear factor-κB ligand via bone morphogenic protein 2

Urolithin A (UA) is an intestinal microbial metabolite derived from ellagitannins and a promising agent for treating osteoarthritis. However, its effects on osteoporosis are unclear. This study explored the effects of urolithin A (UA) on receptor activator of nuclear factor-κB ligand (RANKL)-induced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhe, Qi, Guobin, Li, Zhuokai, Cui, Xu, Guo, Shengyang, Zhang, Yueqi, Cai, Pan, Wang, Xiuhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974137/ https://www.ncbi.nlm.nih.gov/pubmed/35164658 http://dx.doi.org/10.1080/21655979.2022.2036893

Ejemplares similares

Paeoniflorin Inhibits Receptor Activator for Nuclear Factor κB (RANK) Ligand-Induced Osteoclast Differentiation In Vitro and Particle-Induced Osteolysis In Vivo
por: Li, Zhuokai, et al.
Publicado: (2018)

Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF‐κB pathway
por: Li, Yajun, et al.
Publicado: (2022)

Exosomes Isolated From Bone Marrow Mesenchymal Stem Cells Exert a Protective Effect on Osteoarthritis via lncRNA LYRM4-AS1-GRPR-miR-6515-5p
por: Wang, Xiuhui, et al.
Publicado: (2021)

Extracellular interactions and ligand degradation shape the nodal morphogen gradient
por: Wang, Yin, et al.
Publicado: (2016)

The role of dendritic cells derived osteoclasts in bone destruction diseases
por: Wang, Bo, et al.
Publicado: (2020)

Involvement of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-induced Incomplete Cytokinesis in the Polyploidization of Osteoclasts
por: Takegahara, Noriko, et al.
Publicado: (2016)

Nicotinamide phosphoribosyltransferase inhibits receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation in vitro
por: Baek, Jong Min, et al.
Publicado: (2017)

Extracts of Flavoparmelia sp. Inhibit Receptor Activator of Nuclear Factor-κB Ligand-Mediated Osteoclast Differentiation
por: Kim, Kwang-Jin, et al.
Publicado: (2019)

Inhibitory Effect of Biotransformed-Fucoidan on the Differentiation of Osteoclasts Induced by Receptor for Activation of Nuclear Factor-κB Ligand
por: Park, Bobae, et al.
Publicado: (2022)

Trophinin Is an Important Biomarker and Prognostic Factor in Osteosarcoma: Data Mining from Oncomine and the Cancer Genome Atlas Databases
por: Cai, Pan, et al.
Publicado: (2021)

Baicalein ameliorates osteoporosis via AKT/FOXO1 signaling
por: Cai, Pan, et al.
Publicado: (2021)

To B (Bone Morphogenic Protein-2) or Not to B (Bone Morphogenic Protein-2): Mesenchymal Stem Cells May Explain the Protein’s Role in Osteosarcomagenesis
por: Xu, Chunfeng, et al.
Publicado: (2021)

Evaluation of bone morphogenic proteins in periodontal practice
por: Kaur, Supreet, et al.
Publicado: (2016)

Adrenomedullin inhibits osteoclast differentiation through the suppression of receptor activator of nuclear factor-κB ligand-induced nuclear factor-κB activation in glucocorticoid-induced osteoporosis
por: Liu, Yuanxin, et al.
Publicado: (2017)

Robustness of the Dorsal morphogen gradient with respect to morphogen dosage
por: Al Asafen, Hadel, et al.
Publicado: (2020)

Anti-Müllerian Hormone Negatively Regulates Osteoclast Differentiation by Suppressing the Receptor Activator of Nuclear Factor-κB Ligand Pathway
por: Kim, Jung Ha, et al.
Publicado: (2021)

Fexaramine Inhibits Receptor Activator of Nuclear Factor-κB Ligand-induced Osteoclast Formation via Nuclear Factor of Activated T Cells Signaling Pathways
por: Zheng, Ting, et al.
Publicado: (2017)

Urolithin and Reduced Urolithin Derivatives as Potent Inhibitors of Tyrosinase and Melanogenesis: Importance of the 4-Substituted Resorcinol Moiety
por: Lee, Sanggwon, et al.
Publicado: (2021)

Bone morphogenic protein signaling in spinal cord injury
por: Al-Sammarraie, Nadia, et al.
Publicado: (2021)

Locking plate fixation versus intramedullary nail fixation for the treatment of multifragmentary proximal humerus fractures (OTA/AO type 11C): a preliminary comparison of clinical efficacy
por: Wang, Minghui, et al.
Publicado: (2023)

Interleukin-1 induces receptor activator of nuclear factor-κB ligand-independent osteoclast differentiation in RAW264.7 cells
por: Liao, Rongdong, et al.
Publicado: (2021)

Sinonasal Schwannoma with New Bone Formation Expressing Bone Morphogenic Protein
por: Kodama, Satoru, et al.
Publicado: (2010)

NMR Spectroscopic Identification of Urolithin G, a Novel Trihydroxy Urolithin Produced by Human Intestinal Enterocloster Species
por: Beltrán, David, et al.
Publicado: (2023)

Urolithins: A Prospective Alternative against Brain Aging
por: An, Lei, et al.
Publicado: (2023)

Urolithin A alleviates neuropathic pain and activates mitophagy
por: Wang, Chenyi, et al.
Publicado: (2023)

Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation
por: Jia, Zhe-Kun, et al.
Publicado: (2018)

Humanin suppresses receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation via AMP-activated protein kinase activation
por: Kang, Namju, et al.
Publicado: (2019)

Epithelial Bone Morphogenic Protein 2 and 4 Are Indispensable for Tooth Development
por: Mu, Haibin, et al.
Publicado: (2021)

Increased Bone Mass in Mice after Single Injection of Anti-receptor Activator of Nuclear Factor-κB Ligand-neutralizing Antibody: EVIDENCE FOR BONE ANABOLIC EFFECT OF PARATHYROID HORMONE IN MICE WITH FEW OSTEOCLASTS
por: Furuya, Yuriko, et al.
Publicado: (2011)

Morphogens and growth factor signalling in the myeloma bone-lining niche
por: Morris, Emma V., et al.
Publicado: (2021)

The gut microbiota metabolite urolithin A inhibits NF-κB activation in LPS stimulated BMDMs
por: Abdelazeem, Khalid N. M., et al.
Publicado: (2021)

Expression of bone morphogenic protein in sinonasal inverted papilloma with new bone formation
por: Okamoto, Tomoyo, et al.
Publicado: (2011)

Immunomodulatory Role of Urolithin A on Metabolic Diseases
por: Toney, Ashley Mulcahy, et al.
Publicado: (2021)

Potential of Urolithin A to improve joint health
por: D’Amico, Davide, et al.
Publicado: (2023)

In Silico and In Vitro Study of Antioxidant Potential of Urolithins
por: Marchese, Emanuela, et al.
Publicado: (2023)

Corrigendum: Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation
por: Jia, Zhe-Kun, et al.
Publicado: (2020)

PB2082: BONE MORPHOGENIC PROTEIN-6 PROMOTES THE PROLIFERATION AND INHIBITS APOPTOSIS IN MULTIPLE MYELOMA
por: Fu, Jiaqi, et al.
Publicado: (2023)

Urolithin A ameliorates experimental autoimmune encephalomyelitis by targeting aryl hydrocarbon receptor
por: Shen, Pei-Xin, et al.
Publicado: (2021)

Placotylene A, an Inhibitor of the Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclast Differentiation, from a Korean Sponge Placospongia sp.
por: Kim, Hiyoung, et al.
Publicado: (2014)

Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear κB ligand
por: LV, YUANDONG, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gp3n9afnktj52l74tedmeb6ih9